MariMed Inc (MRMD)

[olivernoyes]

Xavier Becerra and HHS have a December 2, 2023 deadline to report their findings... The timeline is written into the law.

https://www.congress.gov/bill/117th-congress/house-bill/8454/text
Public Law No. 117-215 (12/02/2022)
[117th Congress Public Law 215]
[From the U.S. Government Publishing Office]

This Act may be cited as the ``Medical Marijuana
and Cannabidiol Research Expansion Act''.

TITLE IV--FEDERAL RESEARCH

SEC. 401. <<NOTE: 42 USC 284 note.>> FEDERAL RESEARCH.

(a) <<NOTE: Reports.>> In General.--Not later than 1 year after the
date of enactment of this Act, the Secretary of Health and Human
Services, in coordination with the Director of the National Institutes
of Health and the heads of other relevant Federal agencies, shall submit
to the Caucus on International Narcotics Control, the Committee on the
Judiciary, and the Committee on Health, Education, Labor, and Pensions
of the Senate and the Committee on Energy and Commerce and the Committee
on the Judiciary of the House of Representatives a report on--
(1) the potential therapeutic effects of cannabidiol or
marijuana on serious medical conditions, including intractable
epilepsy;
(2) the potential effects of marijuana, including--
(A) the effect of increasing delta-9-
tetrahydrocannabinol levels on the human body and
developing adolescent brains; and
(B) the effect of various delta-9-
tetrahydrocannabinol levels on cognitive abilities, such
as those that are required to operate motor vehicles or
other heavy equipment; and
(3) <<NOTE: Recommenda- tions.>> the barriers associated
with researching marijuana or cannabidiol in States that have
legalized the use of such substances, which shall include--
(A) recommendations as to how such barriers might be
overcome, including whether public-private partnerships
or Federal-State research partnerships may or should be
implemented to provide researchers with access to
additional strains of marijuana and cannabidiol; and
(B) recommendations as to what safeguards must be in
place to verify--
(i) the levels of tetrahydrocannabinol,
cannabidiol, or other cannabinoids contained in
products obtained from such States is accurate;
and
(ii) that such products do not contain harmful
or toxic components.

[[Page 136 STAT. 2266]]

(b) Activities.--To the extent practicable, the Secretary of Health
and Human Services, either directly or through awarding grants,
contacts, or cooperative agreements, shall expand and coordinate the
activities of the National Institutes of Health and other relevant
Federal agencies to better determine the effects of cannabidiol and
marijuana, as outlined in the report submitted under paragraphs (1) and
(2) of subsection (a).

Approved December 2, 2022.

LEGISLATIVE HISTORY--H.R. 8454:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 168 (2022):
July 26, considered and passed House.
Nov. 16, considered and passed Senate.